Clay DeMarcus
Board Member
Clay joined OrbiMed in 2021 and is a Principal focused on medical technology and other non-therapeutics areas of venture-stage investing. Prior to joining OrbiMed, Clay was a Vice President on the medical technology Equity Research team at BofA Securities. Prior to Equity Research, Clay was an Investment Banking Associate in the healthcare group at BofA Securities. Previously, Clay also worked in management consulting with Accenture Strategy as part of the Operations practice. Clay received a B.Sc. from Vanderbilt University and his M.B.A from Emory University’s Goizueta Business School.
Our Family of Catheters
For restoring blood flow in peripheral and pulmonary vessels
The catheter’s expandable infusion basket allows a controlled and selective infusion of physician-specified fluids.
Available in 7F and 8F sizes.
For restoring blood flow within shorter peripheral and pulmonary vessels
The short basket of the S-B catheter allows navigation and implementation in shorter, more tortuous vessels.
Available in 7F and 8F sizes.
For restoring blood flow in peripheral vessels with extensive thrombus burden
A family of catheters designed to deliver thrombolytics through the expandable infusion basket and along a segment of the catheter shaft.
-